607 related articles for article (PubMed ID: 15388426)
21. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
Shi WF; Zhou J; Qin JP
Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
[TBL] [Abstract][Full Text] [Related]
22. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
23. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program.
Bell JM; Chitsaz M; Turnidge JD; Barton M; Walters LJ; Jones RN
J Clin Microbiol; 2007 May; 45(5):1478-82. PubMed ID: 17344367
[TBL] [Abstract][Full Text] [Related]
25. Complex endemic situation regarding extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a hospital in Slovenia.
Jutersek B; Baraniak A; Zohar-Cretnik T; Storman A; Sadowy E; Gniadkowski M
Microb Drug Resist; 2003; 9 Suppl 1():S25-33. PubMed ID: 14633364
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea.
Yoo JS; Byeon J; Yang J; Yoo JI; Chung GT; Lee YS
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):261-5. PubMed ID: 20462727
[TBL] [Abstract][Full Text] [Related]
27. [Plasmid-mediated cephalosporinase among extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae].
Wang QT; Liu YM; Wang H; Sun HL; Chen MJ; Du XL
Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):487-90. PubMed ID: 15312399
[TBL] [Abstract][Full Text] [Related]
28. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
[TBL] [Abstract][Full Text] [Related]
29. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
30. Occurrence of qnr-positive clinical isolates in Klebsiella pneumoniae producing ESBL or AmpC-type beta-lactamase from five pediatric hospitals in China.
Wang A; Yang Y; Lu Q; Wang Y; Chen Y; Deng L; Ding H; Deng Q; Wang L; Shen X
FEMS Microbiol Lett; 2008 Jun; 283(1):112-6. PubMed ID: 18422623
[TBL] [Abstract][Full Text] [Related]
31. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic and molecular characterization of CTX-M-14 extended-spectrum β-lactamase and plasmid-mediated ACT-like AmpC β-lactamase produced by Klebsiella pneumoniae isolates from chickens in Henan Province, China.
Wu H; Liu BG; Liu JH; Pan YS; Yuan L; Hu GZ
Genet Mol Res; 2012 Sep; 11(3):3357-64. PubMed ID: 23079829
[TBL] [Abstract][Full Text] [Related]
33. [Extended spectrum beta-lactamase types in Klebsiella pneumoniae strains isolated from blood cultures].
Ermertcan S; Limoncu MH; Taşli H
Mikrobiyol Bul; 2008 Jan; 42(1):9-15. PubMed ID: 18444558
[TBL] [Abstract][Full Text] [Related]
34. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005.
Elhani D; Bakir L; Aouni M; Passet V; Arlet G; Brisse S; Weill FX
Clin Microbiol Infect; 2010 Feb; 16(2):157-64. PubMed ID: 19769601
[TBL] [Abstract][Full Text] [Related]
35. Emergence of CTX-M-15 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in Bosnia and Herzegovina.
Dedeic-Ljubovic A; Hukic M; Pfeifer Y; Witte W; Padilla E; López-Ramis I; Albertí S
Clin Microbiol Infect; 2010 Feb; 16(2):152-6. PubMed ID: 19686282
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
Zaoutis TE; Goyal M; Chu JH; Coffin SE; Bell LM; Nachamkin I; McGowan KL; Bilker WB; Lautenbach E
Pediatrics; 2005 Apr; 115(4):942-9. PubMed ID: 15805368
[TBL] [Abstract][Full Text] [Related]
37. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases.
Romero ED; Padilla TP; Hernández AH; Grande RP; Vázquez MF; García IG; García-Rodríguez JA; Muñoz Bellido JL
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):433-7. PubMed ID: 17913435
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Qnr determinants among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae in a Taiwanese hospital, 1999-2005.
Wu JJ; Ko WC; Wu HM; Yan JJ
J Antimicrob Chemother; 2008 Jun; 61(6):1234-9. PubMed ID: 18356152
[TBL] [Abstract][Full Text] [Related]
40. Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.
Wong-Beringer A; Hindler J; Loeloff M; Queenan AM; Lee N; Pegues DA; Quinn JP; Bush K
Clin Infect Dis; 2002 Jan; 34(2):135-46. PubMed ID: 11740699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
